MGIM
EVH icon

M&G Investment Management’s Evolent Health EVH Stock Holding History

M&G Investment Management’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-247,462
Closed -$7.67K – 579
2021
Q3 		$7.67K Sell
247,462
-29,697
-11% -$713K 0.02% 321
2021
Q2 		$5.82K Buy
+277,159
New +$5.55M 0.01% 376

Other funds holding EVH

EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

M&G Investment Management's EVH Position: Q4 2021 in Review

M&G Investment Management sold out of Evolent Health (EVH) in Q4 2021, closing a stake of 247,462 shares — an estimated $7.67K sold.

M&G Investment Management first reported a position in EVH in Q2 2021 and held it in 2 quarters. The position peaked at $7.67K in Q3 2021. 207 funds tracked by Wall St. Rank hold EVH as of Q4 2021.

  • M&G Investment Management reported no remaining Evolent Health position as of Q4 2021 after selling out during the quarter.
  • M&G Investment Management sold 247,462 Evolent Health shares in Q4 2021, an estimated $7.67K.
  • M&G Investment Management first reported a position in Evolent Health in Q2 2021 and held it in 2 quarters.
  • M&G Investment Management's Evolent Health position peaked at $7.67K in Q3 2021.
  • 207 funds tracked by Wall St. Rank held Evolent Health as of Q4 2021.

Based on M&G Investment Management's 13F filing for Q4 2021, filed 18 Jan 2022.